Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Treasury Shares (2016 - 2025)

Ptc Therapeutics (PTCT) has 13 years of Treasury Shares data on record, last reported at $3.7 million in Q4 2025.

  • For Q4 2025, Treasury Shares rose 3.96% year-over-year to $3.7 million; the TTM value through Dec 2025 reached $3.7 million, up 3.96%, while the annual FY2025 figure was $3.7 million, 3.96% up from the prior year.
  • Treasury Shares reached $3.7 million in Q4 2025 per PTCT's latest filing, down from $3.8 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $3.9 million in Q1 2025 and bottomed at $1.5 million in Q1 2021.
  • Average Treasury Shares over 5 years is $3.0 million, with a median of $3.5 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: skyrocketed 68.27% in 2022, then dropped 0.39% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $1.5 million in 2021, then skyrocketed by 65.57% to $2.5 million in 2022, then rose by 13.91% to $2.9 million in 2023, then increased by 23.07% to $3.5 million in 2024, then increased by 3.96% to $3.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $3.7 million in Q4 2025, $3.8 million in Q3 2025, and $3.8 million in Q2 2025.